# Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors

> **NCT01165385** · PHASE1 · COMPLETED · sponsor: **UNICANCER** · enrollment: 35 (actual)

## Conditions studied

- Solid Tumors
- Metastatic Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT01165385
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-10
- **Final completion:** 2014-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01165385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01165385, "Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01165385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*